Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2026 100.83M
June 30, 2026 97.93M
March 31, 2026 97.49M
December 31, 2025 95.34M
September 30, 2025 91.08M
June 30, 2025 86.00M
March 31, 2025 85.98M
December 31, 2024 85.32M
September 30, 2024 84.71M
June 30, 2024 82.99M
March 31, 2024 82.13M
December 31, 2023 80.95M
September 30, 2023 80.87M
June 30, 2023 80.68M
March 31, 2023 75.06M
December 31, 2022 74.87M
September 30, 2022 74.83M
June 30, 2022 74.68M
March 31, 2022 74.64M
December 31, 2021 74.61M
September 30, 2021 74.58M
June 30, 2021 74.42M
March 31, 2021 74.09M
December 31, 2020 73.69M
September 30, 2020 73.67M
Date Value
June 30, 2020 73.03M
March 31, 2020 69.04M
December 31, 2019 68.53M
September 30, 2019 66.67M
June 30, 2019 59.38M
March 31, 2019 59.30M
December 31, 2018 59.05M
September 30, 2018 59.04M
June 30, 2018 58.93M
March 31, 2018 58.90M
December 31, 2017 22.80M
September 30, 2017 22.78M
June 30, 2017 22.61M
March 31, 2017 22.54M
December 31, 2016 22.06M
September 30, 2016 21.89M
June 30, 2016 21.84M
March 31, 2016 21.73M
December 31, 2015 21.55M
September 30, 2015 21.27M
June 30, 2015 21.06M
March 31, 2015 20.91M
December 31, 2014 20.48M
September 30, 2014 20.46M
June 30, 2014 20.23M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Electromed, Inc. 8.237M
CVRx, Inc. 28.49M
Accuray, Inc. 2.989M
Orthofix Medical, Inc. 40.75M
ResMed, Inc. 140.64M